Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer Moonshot^SM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Notice of Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status Sort descending	Expiration Date	Program Official
Basic Research in Cancer Health Disparities	PAR-21-322 (R01 Clinical Trial Not Allowed)	R01	Clinical Trial Not Allowed	09/08/2024	Asad Umar, D.V.M., Ph.D.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics	PAR-23-280 (R21 Clinical Trial Not Allowed)	R21	Clinical Trial Not Allowed	01/08/2027	Edward Sauter, M.D., Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer	PAR-23-313 (UH2/UH3 Clinical Trial Not Allowed)	UH2, UH3	Clinical Trial Not Allowed	10/15/2026	Sudhir Srivastava, Ph.D., M.P.H.
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices	RFA-EB-22-002 (R18 Clinical Trial Not Allowed)	R18	Clinical Trial Not Allowed	06/18/2025	Rachel Altshuler, Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers	PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed)	R00, K99	Clinical Trial Not Allowed	10/15/2026	Jessica Faupel-Badger, Ph.D., M.P.H.
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)	PAR-22-114		Clinical Trial Optional	01/24/2025	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities	PAR-22-064 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	01/08/2025	Ellen Richmond, M.S., G.N.P.-B.C.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research	RFA-CA-24-012 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research	RFA-CA-24-014 (P50 Clinical Trial Optional)	P50	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research	RFA-CA-24-013 (U01 Clinical Trial Optional)	U01	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.